NBIX
NEUROCRINE BIOSCIENCES INC
Nasdaq: NBIX · San Diego, CA · Healthcare
$155.64-2.71 (-1.71%)Closed
Market Cap$15.81B
Cash$702.9Mmost recent
Runwayprofitable
P/E (TTM)33.3EPS $4.67
52-Wk Range$123.10 – $185.50
Avg Volume1.1M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$155.64+28.4%
Pipeline
Drug candidates sponsored by NBIX · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for NBIX. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.